Rapid Micro Biosystems issues Q4 and FY23 guidance

RPID Stock  USD 1.15  0.04  3.60%   
About 71 percent of all Rapid Micro's shareholders are curious in acquiring. The analysis of overall sentiment of trading Rapid Micro Biosystems stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Rapid Micro's historical and current headlines, can help investors time the market. In addition, many technical investors use Rapid Micro Biosystems stock news signals to limit their universe of possible portfolio assets.
  
Rapid Micro Biosystems expects Q4 total revenue of 6.2M and 6.4M, representing growth of approximately 45 percent compared to the prior-year...

Read at seekingalpha.com
seekingalpha News
  

Rapid Micro Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Rapid Micro can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Rapid Micro Fundamental Analysis

We analyze Rapid Micro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rapid Micro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rapid Micro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Rapid Micro is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Rapid Micro Biosystems Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rapid Micro stock to make a market-neutral strategy. Peer analysis of Rapid Micro could also be used in its relative valuation, which is a method of valuing Rapid Micro by comparing valuation metrics with similar companies.

Peers

Rapid Micro Related Equities

AIMDAinos   6.82   
0%
100.0%
ELMDElectromed   6.13   
0%
89.0%
LUNGPulmonx Corp   5.76   
0%
84.0%
TIVCTivic Health   4.17   
0%
61.0%
OWLTOwlet   3.17   
0%
46.0%
LNSRLENSAR   2.34   
0%
34.0%
VVOSVivos Therapeutics   2.08   
0%
30.0%
AXGNAxogen   1.83   
0%
26.0%
BVSBioventus   1.74   
0%
25.0%
BBLGBone Biologics   1.63   
0%
23.0%
OFIXOrthofix Medical   1.23   
0%
18.0%
BJDXBluejay Diagnostics   0.57   
0%
8.0%
SRDXSurModics   0.36   
0%
5.0%
KIDSOrthopediatrics Corp   0.49   
7.0%
0%
RXSTRxsight   0.49   
7.0%
0%
LIVNLivaNova PLC   0.74   
10.0%
0%
IRIXIRIDEX   1.15   
16.0%
0%
TMCITreace Medical   1.39   
20.0%
0%

Complementary Tools for Rapid Stock analysis

When running Rapid Micro's price analysis, check to measure Rapid Micro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapid Micro is operating at the current time. Most of Rapid Micro's value examination focuses on studying past and present price action to predict the probability of Rapid Micro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapid Micro's price. Additionally, you may evaluate how the addition of Rapid Micro to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance